Copyright Reports & Markets. All rights reserved.

Global Consumer Healthcare Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Consumer Healthcare Drug by Type
    • 1.3.1 Overview: Global Consumer Healthcare Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Consumer Healthcare Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Solid Preparations
    • 1.3.4 Oral Liquid
    • 1.3.5 Patch
    • 1.3.6 Other
  • 1.4 Global Consumer Healthcare Drug Market by Application
    • 1.4.1 Overview: Global Consumer Healthcare Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Consumer Healthcare Drug Market Size & Forecast
  • 1.6 Global Consumer Healthcare Drug Market Size and Forecast by Region
    • 1.6.1 Global Consumer Healthcare Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Consumer Healthcare Drug Market Size by Region, (2021-2032)
    • 1.6.3 North America Consumer Healthcare Drug Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Consumer Healthcare Drug Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Consumer Healthcare Drug Market Size and Prospect (2021-2032)
    • 1.6.6 South America Consumer Healthcare Drug Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Consumer Healthcare Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Consumer Healthcare Drug Product and Solutions
    • 2.1.4 Johnson & Johnson Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 AbbVie
    • 2.2.1 AbbVie Details
    • 2.2.2 AbbVie Major Business
    • 2.2.3 AbbVie Consumer Healthcare Drug Product and Solutions
    • 2.2.4 AbbVie Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AbbVie Recent Developments and Future Plans
  • 2.3 Merck & Co.
    • 2.3.1 Merck & Co. Details
    • 2.3.2 Merck & Co. Major Business
    • 2.3.3 Merck & Co. Consumer Healthcare Drug Product and Solutions
    • 2.3.4 Merck & Co. Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck & Co. Recent Developments and Future Plans
  • 2.4 GlaxoSmithKline
    • 2.4.1 GlaxoSmithKline Details
    • 2.4.2 GlaxoSmithKline Major Business
    • 2.4.3 GlaxoSmithKline Consumer Healthcare Drug Product and Solutions
    • 2.4.4 GlaxoSmithKline Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Consumer Healthcare Drug Product and Solutions
    • 2.5.4 Pfizer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Recent Developments and Future Plans
  • 2.6 Sanofi
    • 2.6.1 Sanofi Details
    • 2.6.2 Sanofi Major Business
    • 2.6.3 Sanofi Consumer Healthcare Drug Product and Solutions
    • 2.6.4 Sanofi Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sanofi Recent Developments and Future Plans
  • 2.7 Takeda
    • 2.7.1 Takeda Details
    • 2.7.2 Takeda Major Business
    • 2.7.3 Takeda Consumer Healthcare Drug Product and Solutions
    • 2.7.4 Takeda Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Takeda Recent Developments and Future Plans
  • 2.8 Bayer
    • 2.8.1 Bayer Details
    • 2.8.2 Bayer Major Business
    • 2.8.3 Bayer Consumer Healthcare Drug Product and Solutions
    • 2.8.4 Bayer Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Bayer Recent Developments and Future Plans
  • 2.9 Teva
    • 2.9.1 Teva Details
    • 2.9.2 Teva Major Business
    • 2.9.3 Teva Consumer Healthcare Drug Product and Solutions
    • 2.9.4 Teva Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Teva Recent Developments and Future Plans
  • 2.10 Sinopharm Group
    • 2.10.1 Sinopharm Group Details
    • 2.10.2 Sinopharm Group Major Business
    • 2.10.3 Sinopharm Group Consumer Healthcare Drug Product and Solutions
    • 2.10.4 Sinopharm Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sinopharm Group Recent Developments and Future Plans
  • 2.11 CR Pharmaceutical
    • 2.11.1 CR Pharmaceutical Details
    • 2.11.2 CR Pharmaceutical Major Business
    • 2.11.3 CR Pharmaceutical Consumer Healthcare Drug Product and Solutions
    • 2.11.4 CR Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 CR Pharmaceutical Recent Developments and Future Plans
  • 2.12 Shanghai Pharmaceuticals
    • 2.12.1 Shanghai Pharmaceuticals Details
    • 2.12.2 Shanghai Pharmaceuticals Major Business
    • 2.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Product and Solutions
    • 2.12.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shanghai Pharmaceuticals Recent Developments and Future Plans
  • 2.13 Hualan Bio
    • 2.13.1 Hualan Bio Details
    • 2.13.2 Hualan Bio Major Business
    • 2.13.3 Hualan Bio Consumer Healthcare Drug Product and Solutions
    • 2.13.4 Hualan Bio Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hualan Bio Recent Developments and Future Plans
  • 2.14 North China Pharmaceutical
    • 2.14.1 North China Pharmaceutical Details
    • 2.14.2 North China Pharmaceutical Major Business
    • 2.14.3 North China Pharmaceutical Consumer Healthcare Drug Product and Solutions
    • 2.14.4 North China Pharmaceutical Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 North China Pharmaceutical Recent Developments and Future Plans
  • 2.15 Hengrui Medicine
    • 2.15.1 Hengrui Medicine Details
    • 2.15.2 Hengrui Medicine Major Business
    • 2.15.3 Hengrui Medicine Consumer Healthcare Drug Product and Solutions
    • 2.15.4 Hengrui Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hengrui Medicine Recent Developments and Future Plans
  • 2.16 Fosun Pharma
    • 2.16.1 Fosun Pharma Details
    • 2.16.2 Fosun Pharma Major Business
    • 2.16.3 Fosun Pharma Consumer Healthcare Drug Product and Solutions
    • 2.16.4 Fosun Pharma Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Fosun Pharma Recent Developments and Future Plans
  • 2.17 East China Medicine
    • 2.17.1 East China Medicine Details
    • 2.17.2 East China Medicine Major Business
    • 2.17.3 East China Medicine Consumer Healthcare Drug Product and Solutions
    • 2.17.4 East China Medicine Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 East China Medicine Recent Developments and Future Plans
  • 2.18 Livzon Group
    • 2.18.1 Livzon Group Details
    • 2.18.2 Livzon Group Major Business
    • 2.18.3 Livzon Group Consumer Healthcare Drug Product and Solutions
    • 2.18.4 Livzon Group Consumer Healthcare Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Livzon Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Consumer Healthcare Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Consumer Healthcare Drug by Company Revenue
    • 3.2.2 Top 3 Consumer Healthcare Drug Players Market Share in 2025
    • 3.2.3 Top 6 Consumer Healthcare Drug Players Market Share in 2025
  • 3.3 Consumer Healthcare Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Consumer Healthcare Drug Market: Region Footprint
    • 3.3.2 Consumer Healthcare Drug Market: Company Product Type Footprint
    • 3.3.3 Consumer Healthcare Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Consumer Healthcare Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Consumer Healthcare Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Consumer Healthcare Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Consumer Healthcare Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Consumer Healthcare Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Consumer Healthcare Drug Market Size by Application (2021-2032)
  • 6.3 North America Consumer Healthcare Drug Market Size by Country
    • 6.3.1 North America Consumer Healthcare Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Consumer Healthcare Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Consumer Healthcare Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Consumer Healthcare Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Consumer Healthcare Drug Market Size by Country
    • 7.3.1 Europe Consumer Healthcare Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Consumer Healthcare Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Consumer Healthcare Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region
    • 8.3.1 Asia-Pacific Consumer Healthcare Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Consumer Healthcare Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Consumer Healthcare Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Consumer Healthcare Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Consumer Healthcare Drug Market Size by Country
    • 9.3.1 South America Consumer Healthcare Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Consumer Healthcare Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Consumer Healthcare Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country
    • 10.3.1 Middle East & Africa Consumer Healthcare Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Consumer Healthcare Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Consumer Healthcare Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Consumer Healthcare Drug Market Drivers
  • 11.2 Consumer Healthcare Drug Market Restraints
  • 11.3 Consumer Healthcare Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Consumer Healthcare Drug Industry Chain
  • 12.2 Consumer Healthcare Drug Upstream Analysis
  • 12.3 Consumer Healthcare Drug Midstream Analysis
  • 12.4 Consumer Healthcare Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Consumer Healthcare Drug market size was valued at US$ 150020 million in 2025 and is forecast to a readjusted size of US$ 215510 million by 2032 with a CAGR of 5.4% during review period.
    Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Consumer Healthcare Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Consumer Healthcare Drug market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Consumer Healthcare Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Consumer Healthcare Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Consumer Healthcare Drug market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Consumer Healthcare Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Consumer Healthcare Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, AbbVie, Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Takeda, Bayer, Teva, Sinopharm Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Consumer Healthcare Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Solid Preparations
    Oral Liquid
    Patch
    Other
    Market segment by Application
    Hospital
    Retail Pharmacy
    Other
    Market segment by players, this report covers
    Johnson & Johnson
    AbbVie
    Merck & Co.
    GlaxoSmithKline
    Pfizer
    Sanofi
    Takeda
    Bayer
    Teva
    Sinopharm Group
    CR Pharmaceutical
    Shanghai Pharmaceuticals
    Hualan Bio
    North China Pharmaceutical
    Hengrui Medicine
    Fosun Pharma
    East China Medicine
    Livzon Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Consumer Healthcare Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Consumer Healthcare Drug, with revenue, gross margin, and global market share of Consumer Healthcare Drug from 2021 to 2026.
    Chapter 3, the Consumer Healthcare Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Consumer Healthcare Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Consumer Healthcare Drug.
    Chapter 13, to describe Consumer Healthcare Drug research findings and conclusion.

    Buy now